mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |